Elsevier Participates in Project to Make R&D Investments More Transparent

  Elsevier Participates in Project to Make R&D Investments More Transparent

  PR Newswire

  AMSTERDAM, November 22, 2012

AMSTERDAM, November 22, 2012 /PRNewswire/ --

     FundRef aims to standardize reporting of funding sources of research

Elsevier , a world-leading provider of scientific, technical, and medical
information products and services, today highlights its participation in
FundRef, a collaborative pilot project between scholarly publishers and
funding agencies, facilitated by CrossRef . The aim of the project is to
develop a standard mechanism for gathering and disseminating information about
funding sources of published scholarly research.

Currently governments and other research funders do not have an easy or
standard way to track publications that result from their funding. As they are
increasingly required to report on the outcomes of the research they have
supported, this becomes a problem. At the same time, standard bibliographic
data for scholarly publications do not always include funding source
information, which means mining publication data to track funding sources is
difficult. FundRef aims to provide a solution for both problems.

Elsevier's participation in the pilot is marked by its provision of a funding
body registry that provides a standardized taxonomy of 4,000 international
funding agencies, including unique IDs for each. The registry is based on
Elsevier's existing SciVal Funding content that includes a comprehensive
database of funding opportunities from Australia, Canada, the European
Commission, India, Ireland, New Zealand, Singapore, South Africa, United
Kingdom and the United States. The funding body list is freely available at
http://info.scival.com/funding and as linked data via our APIs at
http://data.elsevier.com .

"It is critical for governments and research funders to be accountable for
reporting the research and development outcomes they support, which is
currently almost impossible to connect," said Ed Pentz, Executive Director at
CrossRef. "This initiative provides funders and scholarly publishers with a
unique opportunity to collaborate on a standard that will make R&D investments
more transparent."

"Elsevier is pleased to provide the master list of 4,000 funding agencies to
this initiative and anyone else interested to utilize it," said Chris Shillum
, Vice President, Product Management, Platform & Content at Elsevier and
CrossRef Board member. "We are excited about the potential outcomes of this
collaboration and will continue to support the FundRef initiative in expanding
transparency of research funding information."

At the end of the pilot, with the workflow for submission and dissemination
fully tested, Elsevier intends to incorporate funding identifiers into its
publication submission process. This will provide the funding agencies with
the ability to match their identifiers with CrossRef DOIs of published papers
and clearly track their investments and demonstrate to the public the impact
and benefits they are contributing to society.

Other organizations collaborating with FundRef as part of the initiative
include: American Institute of Physics (AIP), the United States Department of
Energy (DOE), American Psychological Association (APA), United States National
Aeronautics and Space Administration (NASA), National Science Foundation,
IEEE, Wellcome Trust, Nature Publishing Group, Oxford University Press, and
Wiley.

About CrossRef

CrossRef creates services for the scholarly community that require technical
and business collaboration among organizations that cannot be done more
efficiently by a single entity. The deposit and query infrastructure, as well
as the business agreements in place, already provide a way for a large number
of publisher members to share metadata to accomplish reference linking,
Cited-by linking, plagiarism screening, and version tracking. FundRef meets
these criteria, and can be provided with a minimum of new overhead and
investment. More information can be found at:
http://www.crossref.org/fundref/index.html .

About the Elsevier SciVal Suite

Elsevier's SciVal suite of services supports academic and government
leadership in evaluating, establishing and executing research strategies that
optimize the performance of existing assets and maximize investments to
enhance near and long-term productivity. SciVal tools leverage Scopus data,
Elsevier's trusted source of bibliometric data, to offer innovative yet
authoritative solutions. Current suite offerings include: SciVal Spotlight, a
strategic tool that generates unique institutional and country maps of
existing and emerging research strengths based on an interdisciplinary
perspective of current performance; SciVal Funding, an online solution that
provides targeted recommendations on grants to pursue based on pre-populated
research profiles and historical awards; SciVal Strata, a web-based research
performance tool that offers users the flexibility to construct relevant
contextual data to evaluate research teams or individual researchers, using a
range of indicators based on Scopus data; SciVal Experts, a semantic
technology-based application that enables researchers to identify and locate
sources of expertise at an individual or departmental level within and across
institutions. More information can be found at: http://info.scival.com/

About Elsevier Elsevier is a world-leading provider of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet and Cell , and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier's
online solutions include ScienceDirect , Scopus , Reaxys , ClinicalKey and
Mosby's Nursing Suite , which enhance the productivity of science and health
professionals, and the SciVal suite and MEDai's Pinpoint Review , which help
research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC , a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL
(London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Iris Kisjes Elsevier +31-20-485-3072 i.kisjes@elsevier.com 
 
Press spacebar to pause and continue. Press esc to stop.